InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2024-09-11 00:00:00 ET · period of report 2024-09-09 · accession 0001415889-24-023264 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-09-11 2024-09-09 WGS Feeley Kevin CFO S - Sale+OE $33.33 -895 39.9K -2% -$29.8K
D 2024-09-11 2024-09-09 WGS Feeley Kevin CFO M - OptEx $0.00 +2,462 40.8K +6% $0
D 2024-09-11 2024-09-09 WGS Feeley Kevin CFO M - OptEx $0.00 -2,462 22.2K -10% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-09-09 S D 895 $33.33 39,910 D — —
2 Common Class A Common Stock 2024-09-09 M A 2,462 $0.00 40,805 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
3 Derivative Restricted Stock Unit 2024-09-09 M D 2,462 $0.00 22,159 D — · — to — 2,462 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.